Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
CTP’s Progress Addressing the RUF Recommendations
A statement from CTP Director Brian King summarizes the center’s continued efforts to address the Reagan-Udall Foundation’s (RUF) recommendations.
FDA Denies Marketing of Six Flavored Vuse Alto E-Cigarette Products
Company Must Stop Marketing Unauthorized Products or Risk Enforcement
FDA Seeks Fines Against 22 Retailers for Selling Illegal E-Cigarettes
Agency Took Actions After Retailers Failed to Heed Warning Letters
Tobacco Product Marketing Granted Orders (MGO)
To date, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products that currently may be lawfully sold in the U.S. The distribution or sale of unlawfully marketed products is subject to enforcement action.
See the Legal E-Cigarette Products to Sell and Other MGOsActions to Address Recommendations from the Reagan-Udall Foundation Evaluation
At the request of FDA Commissioner Dr. Robert Califf, an independent expert panel facilitated by the Reagan-Udall Foundation (RUF) conducted an operational evaluation of CTP. A final report from the RUF evaluation included 15 recommendations, and in February 2023, CTP published a webpage with detailed plans to address each of the recommendations as quickly as possible. This webpage will be updated routinely to reflect CTP’s latest progress.
Learn About CTP’s Actions to Address the RUF EvaluationContact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: [email protected]
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002